| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Late presentation for human immunodeficiency virus care in the United States and Canada.
|
Clin Infect Dis
|
2010
|
3.72
|
|
2
|
Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).
|
Int J Epidemiol
|
2007
|
3.46
|
|
3
|
Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapy.
|
AIDS
|
2006
|
3.11
|
|
4
|
Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study.
|
J Acquir Immune Defic Syndr
|
2013
|
2.78
|
|
5
|
Early retention in HIV care and viral load suppression: implications for a test and treat approach to HIV prevention.
|
J Acquir Immune Defic Syndr
|
2012
|
2.74
|
|
6
|
Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy.
|
AIDS
|
2003
|
2.66
|
|
7
|
Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America.
|
Clin Infect Dis
|
2012
|
2.50
|
|
8
|
U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008.
|
Ann Intern Med
|
2012
|
2.18
|
|
9
|
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America.
|
Clin Infect Dis
|
2009
|
2.05
|
|
10
|
Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era.
|
J Natl Cancer Inst
|
2013
|
1.96
|
|
11
|
Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009.
|
Clin Infect Dis
|
2013
|
1.94
|
|
12
|
Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy.
|
Clin Infect Dis
|
2011
|
1.91
|
|
13
|
Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study.
|
Ann Intern Med
|
2015
|
1.86
|
|
14
|
Paradoxical immune reconstitution inflammatory syndrome in HIV-infected patients treated with combination antiretroviral therapy after AIDS-defining opportunistic infection.
|
Clin Infect Dis
|
2011
|
1.82
|
|
15
|
Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis.
|
J Acquir Immune Defic Syndr
|
2013
|
1.72
|
|
16
|
The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals.
|
AIDS Patient Care STDS
|
2008
|
1.68
|
|
17
|
An internationally generalizable risk index for mortality after one year of antiretroviral therapy.
|
AIDS
|
2013
|
1.64
|
|
18
|
Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovir.
|
AIDS
|
2007
|
1.60
|
|
19
|
Routine collection of patient-reported outcomes in an HIV clinic setting: the first 100 patients.
|
Curr HIV Res
|
2007
|
1.55
|
|
20
|
Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy.
|
AIDS
|
2011
|
1.52
|
|
21
|
A structural equation model of HIV-related stigma, depressive symptoms, and medication adherence.
|
AIDS Behav
|
2012
|
1.40
|
|
22
|
Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care.
|
AIDS
|
2012
|
1.38
|
|
23
|
Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response.
|
AIDS
|
2008
|
1.33
|
|
24
|
Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy.
|
Clin Infect Dis
|
2013
|
1.31
|
|
25
|
High levels of antiretroviral use and viral suppression among persons in HIV care in the United States, 2010.
|
J Acquir Immune Defic Syndr
|
2013
|
1.23
|
|
26
|
Substance use among HIV-infected patients engaged in primary care in the United States: findings from the Centers for AIDS Research Network of Integrated Clinical Systems cohort.
|
Am J Public Health
|
2013
|
1.18
|
|
27
|
Impact of age on retention in care and viral suppression.
|
J Acquir Immune Defic Syndr
|
2015
|
1.17
|
|
28
|
CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?
|
AIDS Res Ther
|
2010
|
1.13
|
|
29
|
Migrating from a legacy fixed-format measure to CAT administration: calibrating the PHQ-9 to the PROMIS depression measures.
|
Qual Life Res
|
2011
|
1.13
|
|
30
|
Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening.
|
J Infect Dis
|
2011
|
1.11
|
|
31
|
Initiating highly active antiretroviral therapy with newer protease inhibitors is associated with better survival compared to first-generation protease inhibitors or nevirapine.
|
AIDS Patient Care STDS
|
2007
|
1.07
|
|
32
|
Disparities in the quality of HIV care when using US Department of Health and Human Services indicators.
|
Clin Infect Dis
|
2014
|
1.06
|
|
33
|
Patient reported outcomes in routine care: advancing data capture for HIV cohort research.
|
Clin Infect Dis
|
2011
|
1.04
|
|
34
|
Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical care.
|
AIDS
|
2011
|
1.03
|
|
35
|
Three years experience with the implementation of a networked electronic medical record in Haiti.
|
AMIA Annu Symp Proc
|
2008
|
1.02
|
|
36
|
HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy.
|
Clin Infect Dis
|
2014
|
1.00
|
|
37
|
Comparative Effectiveness and Toxicity of Statins Among HIV-Infected Patients.
|
Clin Infect Dis
|
2010
|
0.98
|
|
38
|
HIV infection and antiretroviral therapy: effect on hepatitis C virus quasispecies variability.
|
J Infect Dis
|
2006
|
0.98
|
|
39
|
Comparative effectiveness of initial antiretroviral therapy regimens: ACTG 5095 and 5142 clinical trials relative to ART-CC cohort study.
|
J Acquir Immune Defic Syndr
|
2011
|
0.97
|
|
40
|
Independent clinical predictors of impaired response to hepatitis B vaccination in HIV-infected persons.
|
Int J STD AIDS
|
2008
|
0.97
|
|
41
|
Estimation of the standardized risk difference and ratio in a competing risks framework: application to injection drug use and progression to AIDS after initiation of antiretroviral therapy.
|
Am J Epidemiol
|
2014
|
0.96
|
|
42
|
Association of early HIV viremia with mortality after HIV-associated lymphoma.
|
AIDS
|
2013
|
0.92
|
|
43
|
Laboratory Measures as Proxies for Primary Care Encounters: Implications for Quantifying Clinical Retention Among HIV-Infected Adults in North America.
|
Am J Epidemiol
|
2015
|
0.90
|
|
44
|
A single-item measure of health-related quality-of-life for HIV-infected patients in routine clinical care.
|
AIDS Patient Care STDS
|
2006
|
0.87
|
|
45
|
Poorly Controlled HIV Infection: An Independent Risk Factor for Liver Fibrosis.
|
J Acquir Immune Defic Syndr
|
2016
|
0.84
|
|
46
|
Diabetes case identification methods applied to electronic medical record systems: their use in HIV-infected patients.
|
Curr HIV Res
|
2006
|
0.82
|
|
47
|
Factors associated with delayed hepatitis B viral suppression on tenofovir among patients coinfected with HBV-HIV in the CNICS cohort.
|
J Acquir Immune Defic Syndr
|
2014
|
0.82
|
|
48
|
Somatic symptoms and the association between hepatitis C infection and depression in HIV-infected patients.
|
AIDS Care
|
2011
|
0.82
|
|
49
|
Relationship of immunologic response to antiretroviral therapy with non-AIDS defining cancer incidence.
|
AIDS
|
2014
|
0.81
|
|
50
|
Comparative effectiveness of fish oil versus fenofibrate, gemfibrozil, and atorvastatin on lowering triglyceride levels among HIV-infected patients in routine clinical care.
|
J Acquir Immune Defic Syndr
|
2013
|
0.79
|
|
51
|
Cigarette Smokers are Less Likely to Have Undetectable Viral Loads: Results From Four HIV Clinics.
|
J Addict Med
|
2016
|
0.79
|
|
52
|
Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009.
|
PLoS One
|
2013
|
0.78
|
|
53
|
Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared to the General Population.
|
J Acquir Immune Defic Syndr
|
2017
|
0.76
|
|
54
|
Age at cancer diagnosis among persons with AIDS.
|
Ann Intern Med
|
2011
|
0.76
|
|
55
|
Testosterone replacement therapy among HIV-infected men in the CFAR Network of Integrated Clinical Systems.
|
AIDS
|
2015
|
0.76
|
|
56
|
Blood pressure and antiretroviral therapy.
|
AIDS
|
2007
|
0.75
|
|
57
|
A Randomized Controlled Trial Protocol to Evaluate the Effectiveness of an Integrated Care Management Approach to Improve Adherence Among HIV-Infected Patients in Routine Clinical Care: Rationale and Design.
|
JMIR Res Protoc
|
2016
|
0.75
|
|
58
|
Optimal timing of routine vaccination in HIV-infected persons.
|
Curr HIV/AIDS Rep
|
2009
|
0.75
|
|
59
|
Tenofovir-associated decline in renal function.
|
J Infect Dis
|
2008
|
0.75
|
|
60
|
Comparative effectiveness of single versus multiple tablet antiretroviral therapy regimens in clinical HIV practice.
|
Medicine (Baltimore)
|
2017
|
0.75
|
|
61
|
Risk factors for atrial fibrillation in a multi-center US clinical cohort of people with HIV infection.
|
AIDS
|
2022
|
0.75
|
|
62
|
A Flow-Based Model of the HIV Care Continuum in the United States.
|
J Acquir Immune Defic Syndr
|
2017
|
0.75
|
|
63
|
Associations of CD4+ T-cell count, HIV-1 RNA viral load, and antiretroviral therapy with Kaposi sarcoma risk among HIV-infected persons in the United States and Canada.
|
J Acquir Immune Defic Syndr
|
2017
|
0.75
|
|
64
|
The relationship between efavirenz as initial antiretroviral therapy and suicidal thoughts among HIV-infected adults in routine care.
|
J Acquir Immune Defic Syndr
|
2017
|
0.75
|